Medical Condition News

RSS

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

A team of scientists from the University of California, Irvine, believe they have discovered a special antibody which may lead to a treatment for Retinitis Pigmentosa, a condition that causes loss of central vision, as well as night and color vision.

7 Sep 2023

Vaping e-cigarettes can be as harmful to gum and oral health as smoking traditional cigarettes

For years, it has been known that smoking can contribute to serious damage on gum and oral health, with smokers having more gum diseases, more tooth loss, and increased levels of oral cancer.

7 Sep 2023

Scientists elucidate mechanism behind early loss of vaccination protection in people with autoimmune disease

People who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn's disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average.

7 Sep 2023

IU study sheds new light on the genetic underpinnings of Alzheimer's disease

A groundbreaking study led by experts from Indiana University School of Medicine has shed new light on the genetic underpinnings of Alzheimer's disease.

6 Sep 2023

RIT researchers use CRISPR to develop new treatment for degenerative disc disease

Rochester Institute of Technology researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S., according to the Mayo Clinic.

6 Sep 2023

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

The COVID-19 pandemic led to a notable decline in new cancer diagnoses in Manitoba, Canada, particularly affecting breast, colon, and rectal cancers. The study highlights the urgent need for healthcare strategies to mitigate the impact of future disruptions on cancer detection and treatment.

6 Sep 2023

Teen brains with depression show heightened sensitivity to parental criticism

Adolescents with depression show heightened neural activity in response to parental criticism and are less positively impacted by parental praise, according to a study in Psychological Medicine. The research underscores the importance of psycho-education for parents and clinicians to better understand the unique emotional sensitivities of adolescents with depressive disorders.

6 Sep 2023

Cracking the obesity code: The protein leverage hypothesis

The research paper presents an integrative approach to understanding obesity, focusing on the protein leverage hypothesis (PLH) to examine how protein intake affects energy imbalance. It combines insights from nutritional ecology, ecological sciences, and nutritional geometry, suggesting that protein deficiency and amino acid imbalances could drive increased food intake and contribute to obesity.

6 Sep 2023

Enhanced recovery program shows promise in reducing opioid reliance after pancreatic cancer surgery

By improving hospital care pathways, researchers from The University of Texas MD Anderson Cancer Center successfully reduced inpatient opioid use by 50% after pancreatic cancer surgery and cut the median opioid prescription volumes at discharge to zero.

6 Sep 2023

Oral health worsens in morbidly obese people before and after bariatric surgery

Oral health deteriorates in morbidly obese people on a diet in preparation for bariatric surgery and patients who have undergone the procedure, with increasing caries, gingivitis and periodontitis.

6 Sep 2023

Pitt neuroscientists create first non-human primate model of hereditary Alzheimer's in marmosets

To reimagine existing preclinical trials for Alzheimer's disease, University of Pittsburgh School of Medicine neuroscientists created the first non-human primate model of hereditary Alzheimer's in marmoset monkeys, outlining their approach in Alzheimer's & Dementia: Translational Research & Clinical Interventions.

6 Sep 2023

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.

6 Sep 2023

Even in the most depressed county in America, stigma around mental illness persists

Sitting on a bench laughing with a co-worker during a morning smoke break, Debra Orcutt quickly raises her hand when asked if she knows anyone dealing with depression.

6 Sep 2023

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

In a recent review published in Cell, a group of authors delved into the complexities of menopause, assessed its global impacts on health, and evaluated the effectiveness and safety of current treatments, emphasizing the importance of further research.

6 Sep 2023

Study reveals heart failure insights at single-cell level

Researchers examined the cell-intrinsic effects of hematopoietic stem cells with somatic mutations in circulating cells from heart failure patients.

6 Sep 2023

High dietary intake of added sugars could increase the risk of coronary heart disease

The associations between individual dietary sugar types and the risk of coronary heart disease.

6 Sep 2023

Clovibactin - a game-changing novel antibiotic with no resistance

Researchers reported the discovery of a new antibiotic, clovibactin.

6 Sep 2023

Does dahlia flower extract have anti-diabetic properties?

The effects of an extract of yellow petals of Dahlia pinnata as a novel treatment of type 2 diabetes (T2D).

6 Sep 2023

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.

5 Sep 2023

Researchers receive $2.5 million award to develop a tailored treatment for glioblastoma

A multidisciplinary team of investigators from the UCLA Jonsson Comprehensive Cancer Center was awarded a $2.5 million Translational Team Science Award from the Department of Defense to develop a tailored treatment for glioblastoma, a deadly brain tumor with limited treatment options.

5 Sep 2023

Medical Condition News

Newly discovered nanobody may lead to a treatment for Retinitis Pigmentosa

Vaping e-cigarettes can be as harmful to gum and oral health as smoking traditional cigarettes

Scientists elucidate mechanism behind early loss of vaccination protection in people with autoimmune disease

IU study sheds new light on the genetic underpinnings of Alzheimer's disease

RIT researchers use CRISPR to develop new treatment for degenerative disc disease

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

Teen brains with depression show heightened sensitivity to parental criticism

Cracking the obesity code: The protein leverage hypothesis

Enhanced recovery program shows promise in reducing opioid reliance after pancreatic cancer surgery

Oral health worsens in morbidly obese people before and after bariatric surgery

Pitt neuroscientists create first non-human primate model of hereditary Alzheimer's in marmosets

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

Even in the most depressed county in America, stigma around mental illness persists

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

Study reveals heart failure insights at single-cell level

High dietary intake of added sugars could increase the risk of coronary heart disease

Clovibactin - a game-changing novel antibiotic with no resistance

Does dahlia flower extract have anti-diabetic properties?

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers receive $2.5 million award to develop a tailored treatment for glioblastoma

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News